1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use
COMIRNATY safely and effectively. See full prescribing information for
COMIRNATY. COMIRNATY® (COVID-19 Vaccine, mRNA) suspension for injection,
for intramuscular use Initial U.S. Approval: 2021
Individuals using assistive technology may not be able to fully access the information contained
in this file. For assistance, please send an e-mail to: ocod@fda.hhs.gov and include 508
Accommodation and the title of the document in the subject line of your e-mail.
No comments:
Post a Comment